Prevention
Education
Advocacy
Cardio Obstetrics
CCCN
Canadian Association of Interventional Cardiology (CAIC)
Nursing & Allied Health
Maria Lopez Laporte, MDCM
Adult Cardiology Resident PGY-6
University of Ottawa Heart Institute
University of Ottawa Heart Institute
Nazli Parast, RN, CDE, BScN, MN, EdD
Adjunct Professor/Faculty
University of Ottawa Heart Institute
Beth Abramson, MD MSc FRCPC FACC
Cardiologist, Paul Albrechtsen Prof. of CV Prevention, U of T
St. Michael's Hospital
University of Toronto
Jonathan Windram, BSc (Hons), MBChB, MMEd, MRCP (UK), FCCS, FESC
Associate Professor
Mazankowski Heart Institute
Mazankowski Heart Institute
Laurie-Anne Boivin-Proulx, MD MSc
Interventional Cardiology Fellow
University of Ottawa Heart Institute
University of Ottawa Heart Institute
Maria Lopez Laporte, MDCM
Adult Cardiology Resident PGY-6
University of Ottawa Heart Institute
University of Ottawa Heart Institute
Nazli Parast, RN, CDE, BScN, MN, EdD
Adjunct Professor/Faculty
University of Ottawa Heart Institute
Laurie-Anne Boivin-Proulx, MD MSc
Interventional Cardiology Fellow
University of Ottawa Heart Institute
University of Ottawa Heart Institute
Habibat Garuba, MD, FRCPC, BScPhm (Hons)
Cardiologist, Director of the Canadian Women's Heart Health Clinic
CCS
University of Ottawa Faculty of Medicine
Workshop Description: Young women are a uniquely challenging population that make many cardiologists uneasy. Traditional risk assessment tools, such as the Framingham risk score, do not capture the various risk factors that affect this population. Moreover, hormonal fluctuations throughout a woman’s life, whether they are physiologic or pathologic, play a key role in cardiovascular health and disease. In this workshop, we propose a deep dive into the interplay of hormones and heart health in young women, using the 4 P’s as examples to guide discussion. First, we will discuss Polycystic ovarian syndrome, a condition that affects 10% of premenopausal women, and that carries significant cardiometabolic disruption. Tips and tricks to evaluate cardiovascular risk in young women will be discussed. Then, we will tackle the hot topic of assisted reProductive technologies, and their impact on cardiovascular health, focusing on potential complications such as ovarian hyperstimulation syndrome and multiparity, and their impact on heart health. Third, we will explore the mechanisms underlying Preeclampsia-related adverse events and discuss optimal risk reduction interventions. Lastly, we will discuss the unique challenges of accelerated vascular aging and other adverse effects of Premature and early menopause.
To achieve these ambitious objectives, we have recruited a multi-disciplinary team of experts to guide our discussions. One of the strengths of our workshop is the breadth of expertise of our committee members and speakers, which encompass various disciplines, levels of training, and geographic representation across the country, allowing us to provide robust content for this important session.
We expect that this workshop will be of great interest to the general cardiologist as well as subspecialists and will provide a platform for expert discussion on the care of this unique population.